在患有和没有帕金森病的人群中,GBA1变异的表型效应:RAPSODI研究
Marco Toffoli1, Harneek Chohan2, Stephen Mullin3
1Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK; Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, USA.
Neurobiology of disease
|November 5, 2023
概括
GBA1基因中的遗传变异与帕金森病 (PD) 和戈舍病 (GD) 有关. 这项研究发现,GBA1阳性PD患者具有更严重的非运动性症状,但在未受影响的GBA1载体中没有发现prodromalPD迹象.
科学领域:
- 神经遗传学 神经遗传学
- 溶酶体储存障碍 溶酶体储存障碍
- 神经退行性疾病 神经退行性疾病
背景情况:
- GBA1基因中的遗传变异与高氏病 (GD) 有关,也是帕金森病 (PD) 的风险因素.
- 在PD中GBA1变异的不完全透需要识别具有更高风险的载体,用于预后和治疗目的.
- 了解GBA1变异对PD表型的影响对于个性化医学和临床试验设计至关重要.
研究的目的:
- 为了比较携带GBA1变异的人与没有携带GBA1变异的人的运动和非运动临床特征.
- 为了研究非受影响的GBA1变异载体中帕金森病潜在的前性症状.
- 为了阐明与GBA1阳性帕金森病相关的特定表型.
主要方法:
- 来自RAPSODI研究的基线数据的横截面分析,这是PD患者和GBA1载体的在线评估工具.
- 包括经过临床验证的问卷,触摸测试,嗅觉识别测试和认知评估.
- 整合来自PREDICT-PD队列的额外数据,以提高统计能力.
主要成果:
- 与GBA1-阴性PD患者相比,GBA1-阳性PD患者在视觉认知任务和嗅觉方面表现较差.
- 在未受影响的GBA1载体和GBA1-阴性对照之间没有观察到显著的表型差异.
- 在非PD参与者群体中没有检测到表型差异.
结论:
- 这些发现支持现有证据,即GBA1阳性PD的特征是独特的表型,特别是具有更严重的非运动症状.
- 这项研究没有复制之前的发现,表明在携带GBA1变异而没有PD的个体中更频繁的前性PD症状.
- 需要进一步的研究才能充分理解GBA1变异在PD病变和进展中的作用.
相关概念视频
01:15Parkinson's Disease: Overview
564
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
564
01:37Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
01:24Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
01:11Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K